<--- Back to Details
First PageDocument Content
Cardiac dysrhythmia / Antiarrhythmic agents / Channelopathy / Organofluorides / Alcohols / Long QT syndrome / QT interval / Ventricular tachycardia / Ranolazine / Medicine / Chemistry / Organic chemistry
Date: 2012-12-11 19:19:32
Cardiac dysrhythmia
Antiarrhythmic agents
Channelopathy
Organofluorides
Alcohols
Long QT syndrome
QT interval
Ventricular tachycardia
Ranolazine
Medicine
Chemistry
Organic chemistry

Microsoft PowerPoint - ALN202799fig2.ppt

Add to Reading List

Source URL: www.sads.org

Download Document from Source Website

File Size: 744,01 KB

Share Document on Facebook

Similar Documents

Geography of California / American Viticultural Areas / California / Paicines AVA / Merlot / Cabernet Franc / Central Coast AVA / Wine tasting / Columbia Winery / Naches Heights AVA

FA M I LY VINE Y ARD her alcohols are resulting from more sugars being left in solids when al SG’s measured. Sugar is hidden - just like acids. It is best to ure SG’s with pulp solids mixed up. More sugar will show

DocID: 1xVep - View Document

ANALYTICAL • Chemgard® Photoacoustic Infrared Gas Monitors • Detects minute traces of hydrocarbons, solvents, alcohols, CO2, CO and toxics • Density – DSG and MiniTrac Detectors • Interface – Multipoin

DocID: 1uIHs - View Document

ALAN D BARBOUR, PhD, CLB Fellow of The Chartered Society of Forensic Sciences Consulting Forensic Toxicologist Forensic Toxicology • Blood Alcohols • Mass Spectrometry Inspection and evaluation of clinical and toxico

DocID: 1uBCe - View Document

Communication pubs.acs.org/JACS Late-Stage Deoxyfluorination of Alcohols with PhenoFluor Filippo Sladojevich, Sophie I. Arlow, Pingping Tang, and Tobias Ritter* Department of Chemistry and Chemical Biology, Harvard Univ

DocID: 1s9g9 - View Document

Neurochemistry / Chemistry / Drug rehabilitation / Morphinans / Nervous system / Opioid antagonists / Euphoriants / Alcohols / Buprenorphine / Opioid use disorder / Opioid / Methadone

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document